ATLASActinium Pharmaceuticals (ATNM) earnings date: Nov 13, 2026
Actinium Pharmaceuticals (ATNM) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.25.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ATNM
| Last price | $1.46 (-1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Actinium Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Actinium Pharmaceuticals reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Actinium Pharmaceuticals. You can switch it off at any time.
Alert me before ATNM reportsFree to start. Creating an account takes under a minute.
Notify me when Actinium Pharmaceuticals reports
Track ATNM free Add Actinium Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
ATNM earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.25 |
| Last report | Aug 7, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +173.1% |
| Average move around a report | ±4.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Actinium Pharmaceuticals earnings history: last 4 reports
Actinium Pharmaceuticals last reported on Aug 7, 2026: EPS of $0.89 against an estimate of -$0.20 (+545.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.20 | $0.89 | +545.0% | Beat | -2.2% |
| May 8, 2026 | -$0.22 | -$0.18 | +18.2% | Beat | +9.8% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | -5.7% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -0.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ATNM
See the fair value, the probability range and the earnings history of Actinium Pharmaceuticals on its ATLAS page.
Actinium Pharmaceuticals (ATNM) stock analysisPlans from €3.99 a month.
Actinium Pharmaceuticals earnings: frequently asked questions
When does Actinium Pharmaceuticals (ATNM) report earnings?
Actinium Pharmaceuticals is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ATNM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.25 per share (USD). Estimates can change before the report.
How often does ATNM beat earnings estimates?
Of its last 4 reports with a recorded result, Actinium Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +173.1%. Past results do not predict the next one.
How much does ATNM move around earnings?
Over its last 4 reports the stock moved an average of 4.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Actinium Pharmaceuticals beat earnings estimates last quarter?
Actinium Pharmaceuticals last reported on Aug 7, 2026: EPS of $0.89 against an estimate of -$0.20 (+545.0% surprise), a beat.
How much does ATNM usually move in a day?
On a normal trading day the ATLAS model puts ATNM’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer